| Published Application/Species/Sample/Dilution | Reference |
|---|
- immunohistochemistry; rat; loading ...; fig 85
| Furukawa S, Nagaike M, Ozaki K. Databases for technical aspects of immunohistochemistry.. J Toxicol Pathol. 2017;30:79-107 pubmed publisher |
- immunohistochemistry - paraffin section; human; 1:40; loading ...; fig 3
| Posenato I, Cali A, Segala D, Sgroi S, Polara A, Brunelli M, et al. Primary Seminal Vesicle Carcinoma. The Usefulness of Pax8 Immunohistochemical Expression for the Differential Diagnosis.. Hum Pathol. 2017;0: pubmed publisher |
- immunohistochemistry; human; 1:100; fig e5
| Shu S, Lin C, He H, Witwicki R, Tabassum D, Roberts J, et al. Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer. Nature. 2016;529:413-7 pubmed publisher |
- immunohistochemistry - paraffin section; human; 1:300; loading ...
| Ji C, Zhou M, Gan W, Zheng J, Yan X, Guo H. Advanced prostatic ductal carcinoma in a patient with a long survival time following a total pelvis exenteration: A case report. Oncol Lett. 2016;11:1509-1511 pubmed |
- immunohistochemistry - paraffin section; human; 1:200; tbl 2
| Cheung S, Boey Y, Koh V, Thike A, Lim J, Iqbal J, et al. Role of epithelial-mesenchymal transition markers in triple-negative breast cancer. Breast Cancer Res Treat. 2015;152:489-98 pubmed publisher |
- immunohistochemistry; human; 1:200
| Oon M, Thike A, Tan S, Tan P. Cancer stem cell and epithelial-mesenchymal transition markers predict worse outcome in metaplastic carcinoma of the breast. Breast Cancer Res Treat. 2015;150:31-41 pubmed publisher |
- immunohistochemistry - paraffin section; human; 1:200
| Koh V, Lim J, Thike A, Cheok P, Thu M, Tan V, et al. Characteristics and behaviour of screen-detected ductal carcinoma in situ of the breast: comparison with symptomatic patients. Breast Cancer Res Treat. 2015;152:293-304 pubmed publisher |
